/, Interstitial Cystitis Network Blog, Research/Cyclosporine Study Seeks Men and Women Who Have Failed Previous IC/BPS Therapies

Cyclosporine Study Seeks Men and Women Who Have Failed Previous IC/BPS Therapies

Men & Women Welcome To Participate In This Cyclosporine & IC Study

If you are suffering from Interstitial Cystitis (Painful Bladder Syndrome) and have had three or more failed therapies, you may be a candidate for “Cyclosporine in Interstitial Cystitis” study at the Cleveland Clinic. Several research studies have been published showing that Cyclosporine can improve the symptoms of Interstitial Cystitis. It is a government funded study and can be found in clinicaltrials.gov

You may be eligible if you:

  • Are over the age of 18 years.
  • Have been diagnosed with Interstitial Cystitis.
  • Have failed a minimum of three therapies.

Exclusion Criteria:

  • Active Cancer, pelvic radiation, previous urological cancer.
  • Diabetes, serum Creatinine > 1.5 mg/dL, untreated proteinuria, untreated UTI, allergy to iodine, hypersensitivity to cyclosporine.
  • Chronic use of opioid therapy, medication impacting cyclosporine, immunosuppressive medication.
  • Pregnant or breast feeding
  • Urinary diversion or bladder augmentation,
  • Pacemaker.

Location & Duration:

The study involves 4 – 5 visits at 1 month intervals with compensation of $50 for 4 visits. The study location is:

Cleveland Clinic

Cleveland Clinic
Glickman Urological and Kidney Institute
2050 East 96th Street
Cleveland, OH 44195

If interested and/or to learn more, please contact:

Barbara Tucky, MBA, Study Coordinator
216-444-1044
tuckyb@ccf.org

By | 2017-01-31T10:59:36+00:00 October 1st, 2014|Clinical Trials, Interstitial Cystitis Network Blog, Research|Comments Off on Cyclosporine Study Seeks Men and Women Who Have Failed Previous IC/BPS Therapies

About the Author:

My Google Profile+ Jill Heidi Osborne is the president and founder of the Interstitial Cystitis Network, a health education company dedicated to interstitial cystitis, bladder pain syndrome and other pelvic pain disorders. As the editor and lead author of the ICN and the IC Optimist magazine, Jill is proud of the academic recognition that her website has achieved. The University of London rated the ICN as the top IC website for accuracy, credibility, readability and quality. (Int Urogynecol J - April 2013). Harvard Medical School rated both Medscape and the ICN as the top two websites dedicated to IC. (Urology - Sept 11). Jill currently serves on the Congressionally Directed Medical Research Panel (US Army) where she collaborates with researchers to evaluate new IC research studies for possible funding. Jill has conducted and/or collaborates on a variety of IC research studies on new therapeutics, pain care, sexuality, the use of medical marijuana, menopause and the cost of treatments, shining a light on issues that influence patient quality of life. An IC support group leader and national spokesperson for the past 20 years, she has represented the IC community on radio, TV shows, at medical conferences. She has written hundreds of articles on IC and its related conditions. With a Bachelors Degree in Pharmacology and a Masters in Psychology, Jill was named Presidential Management Intern (aka Fellowship) while in graduate school. (She was unable to earn her PhD due to the onset of her IC.) She spends the majority of her time providing WELLNESS COACHING for patients in need and developing new, internet based educational and support tools for IC patients, including the “Living with IC” video series currently on YouTube and the ICN Food List smartphone app! Jill was diagnosed with IC at the age of 32 but first showed symptoms at the age of 12.